Trial intelligence / Profile preview

Timing of loop diuretics in older adults with heart failure

NL-OMON57865Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Jul 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of furosemide and bumetanide in heart failure (HF) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Disease-related quality of life. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

furosemidebumetanide
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NL-OMON57865.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON57865.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call